Research programme: Chagas disease vaccines - Gador/SEEK
Latest Information Update: 24 Dec 2010
At a glance
- Originator PepTcell
- Developer SEEK
- Class Vaccines
- Mechanism of Action T lymphocyte stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Research Chagas disease
Most Recent Events
- 20 Oct 2009 Development is ongoing in the UK
- 17 Dec 2007 Early research in Chagas' disease in United Kingdom (unspecified route)